Jana Medical Company (TADAWUL:9616)

Jana Medical Company Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	5.92	5.41	5.22
Depreciation & Amortization	0.38	0.38	0.22
Other Amortization	0	0	0
Provision & Write-off of Bad Debts	1.12	3.18	0.65
Other Operating Activities	1.87	0.19	0.77
Change in Accounts Receivable	-28.99	-31.16	-32.31
Change in Inventory	6.39	8.74	-7.89
Change in Accounts Payable	8.58	0.64	-0.09
Change in Other Net Operating Assets	15.31	16.54	-2.98
Operating Cash Flow	10.57	3.92	-36.41
Capital Expenditures	-0.02	-0.16	-0.36
Sale (Purchase) of Intangibles	-0.02	-0.08	-0
Investing Cash Flow	-0.04	-0.24	-0.36
Long-Term Debt Issued	-	48.03	29.75
Short-Term Debt Repaid	-	-6.78	-5.72
Long-Term Debt Repaid	-	-44.88	-8.76
Total Debt Repaid	-71.27	-51.66	-14.47
Net Debt Issued (Repaid)	-10.61	-3.63	15.28
Issuance of Common Stock	-	-	22.06
Financing Cash Flow	-10.61	-3.63	37.34
Net Cash Flow	-0.08	0.05	0.57
Free Cash Flow	10.55	3.76	-36.77
Free Cash Flow Margin	16.40%	6.13%	-85.42%
Free Cash Flow Per Share	4.11	1.47	-18.29
Cash Interest Paid	7.09	7.09	2.04
Levered Free Cash Flow	-	-8.58	-
Unlevered Free Cash Flow	-	-5.52	-
Change in Net Working Capital	-	13.5	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.